MYCIFRADIN vs NEOMYCIN SULFATE

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 20, 2026·How we rate

Attribute	MYCIFRADIN	NEOMYCIN SULFATE
Rating	New	48/100
Pharmacy pays	~$25.36 /30	~$25.36 /30
Type	RX	RX
Active ingredient	NEOMYCIN SULFATE	NEOMYCIN SULFATE
Manufacturer	Pharmacia and Upjohn	Teva
Dosage forms	Tablet, Solution	Topical, Tablet
Drug class	Aminoglycoside Antibacterial	Aminoglycoside Antibacterial
Boxed warning	None	Boxed warning
Treats	Escherichia Coli Infections, Hepatic Encephalopathy, Bacterial Skin Diseases	Escherichia Coli Infections, Hepatic Encephalopathy, Bacterial Skin Diseases

mycifradin neomycin sulfate

Rating

New

48/100

Pharmacy pays

~$25.36 /30

Type

Active ingredient

NEOMYCIN SULFATE

Manufacturer

Pharmacia and Upjohn

Teva

Dosage forms

Tablet, Solution

Topical, Tablet

Drug class

Aminoglycoside Antibacterial

Boxed warning

None

Boxed warning

Treats

Escherichia Coli Infections, Hepatic Encephalopathy, Bacterial Skin Diseases

Frequently asked questions

Which is cheaper, Mycifradin or Neomycin Sulfate?

Pharmacies pay about the same to acquire either one — roughly $25.36 for a 30-count supply, per the CMS NADAC survey. That is not what you will be charged: your price is set by your insurer and the pharmacy, not by what the drug cost them.

What is the difference between Mycifradin and Neomycin Sulfate?

Both Mycifradin and Neomycin Sulfate share the active ingredient Neomycin Sulfate.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.